Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 46 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

46 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Sept. 14, 2020 ASTH P 5,000 $17.23 $86,150 42,996 Indirect +13.16% Acquired 108.2% (price as of 2026-10-02)
Sept. 14, 2020 ASTH P 1,000 $17.20 $17,200 17,379 Indirect +6.11% Acquired 108.6% (price as of 2026-10-02)
Sept. 10, 2020 ASTH P 5,000 $17.60 $88,000 37,996 Indirect +15.15% Acquired 103.9% (price as of 2026-10-02)
Sept. 9, 2020 ASTH P 5,000 $17.60 $88,000 37,996 Indirect +15.15% Acquired 103.9% (price as of 2026-10-02)
Aug. 27, 2020 ASTH P 5,000 $18.34 $91,700 1,770,556 Indirect +0.28% Acquired 95.6% (price as of 2026-10-02)
Nov. 14, 2019 ASTH P 10,000 $14.67 $146,700 1,737,561 Indirect +0.58% Acquired 144.6% (price as of 2026-10-02)
Oct. 8, 2019 ASTH P 5,000 $15.55 $77,750 1,727,561 Indirect +0.29% Acquired 130.7% (price as of 2026-10-02)
Aug. 16, 2019 ASTH P 1,500 $16.25 $24,375 1,662,678 Indirect +0.09% Acquired 120.8% (price as of 2026-10-02)
Aug. 16, 2019 ASTH P 437 $16.35 $7,145 1,663,115 Indirect +0.03% Acquired 119.4% (price as of 2026-10-02)
Aug. 16, 2019 ASTH P 563 $16.35 $9,205 1,663,678 Indirect +0.03% Acquired 119.4% (price as of 2026-10-02)
Aug. 15, 2019 ASTH P 1,500 $15.25 $22,875 1,661,178 Indirect +0.09% Acquired 135.3% (price as of 2026-10-02)
Aug. 14, 2019 ASTH P 2,000 $16.23 $32,460 1,659,678 Indirect +0.12% Acquired 121.1% (price as of 2026-10-02)
June 12, 2019 ASTH P 1,300 $14.45 $18,785 1,657,678 Direct +0.08% Acquired 148.3% (price as of 2026-10-02)
June 11, 2019 ASTH P 5,696 $14.51 $82,649 1,656,378 Direct +0.35% Acquired 147.3% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Nov. 10, 2025 ASTH Stock Option (right to buy) Common Stock (29,502) $17.78 Dec. 10, 2025 29,502 Disposed
Nov. 18, 2024 ASTH Stock option (right to buy) Common Stock (28,046) $18.65 Dec. 30, 2024 28,046 Disposed
Dec. 8, 2022 ASTH Warrants to purchase Common Stock Common Stock (51,445) $10.00 Dec. 8, 2022 51,445 Disposed
Dec. 8, 2022 ASTH Warrants to purchase Common Stock Common Stock (48,587) $11.00 Dec. 8, 2022 48,587 Disposed
Nov. 2, 2021 ASTH Stock Option (right to buy) Common Stock (29,502) $71.45 Nov. 2, 2026 29,502 Acquired
March 30, 2021 ASTH Warrant to Purchase Common Stock Common Stock (31,756) $10.00 March 30, 2021 31,756 Disposed
Dec. 10, 2020 ASTH Stock Option (right to buy) Common Stock (29,502) $17.78 Dec. 10, 2025 29,502 Acquired
Sept. 8, 2020 ASTH Warrants to Purchase Common Stock Common Stock (63,512) $9.00 Oct. 14, 2020 63,512 Disposed
Dec. 30, 2019 ASTH Stock Option (right to buy) Common Stock (28,046) · Dec. 30, 2024 28,046 Acquired
Dec. 27, 2019 ASTH Stock Option (right to buy) Common Stock (39,189) · Sept. 30, 2024 39,189 Disposed
Sept. 30, 2019 ASTH Stock Option (right to buy) Common Stock (39,189) · Sept. 30, 2024 39,189 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 12 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
March 29, 2018 ASTH Common Stock [F1,F2] 1,563,804 Direct
March 29, 2018 ASTH Common Stock [F3,F4] 1,682,109 Indirect
Dec. 18, 2017 ASTH Common Stock [F1,F2] 1,547,019 Direct
Dec. 18, 2017 ASTH Common Stock [F3,F6] 1,664,054 Indirect
Dec. 18, 2017 ASTH Warrants to purchase Common Stock [F4]→ Common Stock (63,513) 63,513 Direct
Dec. 18, 2017 ASTH Warrants to purchase Common Stock [F4]→ Common Stock (31,756) 31,756 Direct
Dec. 18, 2017 ASTH Warrants to purchase Common Stock [F2]→ Common Stock (51,445) 51,445 Direct
Dec. 18, 2017 ASTH Warrants to purchase Common Stock [F2]→ Common Stock (48,587) 48,587 Direct
Dec. 18, 2017 ASTH Warrants to purchase Common Stock [F3,F5]→ Common Stock (68,317) 68,317 Indirect
Dec. 18, 2017 ASTH Warrants to purchase Common Stock [F3,F5]→ Common Stock (34,159) 34,159 Indirect
Dec. 18, 2017 ASTH Warrants to purchase Common Stock [F3,F6]→ Common Stock (55,337) 55,337 Indirect
Dec. 18, 2017 ASTH Warrants to purchase Common Stock [F3,F6]→ Common Stock (52,263) 52,263 Indirect

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ASTH

M.D. Executive Chairman
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $950,000 $100,000 · · · · $24,170 $1,074,170
2024 $950,000 · $9,392,000 · · · $20,866 $10,362,866
2022 $950,000 $450,000 · · · · $94,015 $1,494,015

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.